What does Salveo Capital invest in?
Salveo Capital invests most often at Series A and Series B (100% of the rounds on record), in sectors such as Alcohol, Cbd and Gambling.

United States · Investor
Last cheque observed Sep 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
Private equityQuiet
Follow Salveo Capital and see its new cheques in your feed. Start following
8 rounds on record
Mostly Series A and Series B: 100% of its rounds
Led 1 rounds
Salveo Capital's approach is to bring an institutional quality discipline to company vetting, investment structures and portfolio management.From their own website
Every round we can evidence, newest first8 appearances
4 rounds
3 rounds
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
We hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From their own portfolio page (on their website)
Flow_KanaGrassrootscannabisSalveo-HeadsetSalveo-front-range-bio100.jpgCaptureCaptureCaptureCapture.2PNGCapture3Salveo-TreezTrybakerascendhbrsideherblpurissimatokyo smokewürk-logo-2017-fullcolor
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
The investors most often in the same rounds as Salveo Capital. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Salveo Capital put money into.
Salveo Capital invests most often at Series A and Series B (100% of the rounds on record), in sectors such as Alcohol, Cbd and Gambling.
8 investments on record, 0 of them in the last 12 months, and it led 1. The most recent was in Sept 2019.
Its most recent investments on record: PathogenDx (Series B, Sept 2019), Front Range Biosciences (Undisclosed round, Sept 2019) and KelSie Biotech (Series A, May 2019).
The median round it joins is $9.3M.
Sometimes: it led 1 of its 8 investments on record (13%).
Most of the companies it backs are in the United States (100%).
No investments in the last 12 months; the latest was in Sept 2019.
Most often Phyto Partners (3 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it